Revolution Medicines, Inc. (RVMD) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
RVMD Revenue Growth
Revenue Breakdown (FY 2022)
RVMD's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
RVMD Revenue Analysis (2017–2025)
As of May 6, 2026, Revolution Medicines, Inc. (RVMD) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, RVMD's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $50.0 million in 2019.
Revenue diversification analysis shows RVMD's business is primarily driven by Collaboration Revenue Member (100%). With over half of revenue concentrated in Collaboration Revenue Member, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MRSN (-4.8% YoY), ARVN (-0.3% YoY), and TNGX (+48.3% YoY). Compare RVMD vs MRSN →
RVMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RVMDCurrent | $0 | - | - | - | |
 MRSN | $40M | -4.8% | -0.8% | -181.1% | |
 ARVN | $263M | -0.3% | +58.9% | -43.8% | |
 TNGX | $62M | +48.3% | +52.1% | -178.4% |
RVMD Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-16,558,000 | - | $-1,182,369,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-689,524,000 | - |
| 2023 | $11.6M | -67.3% | $11.6M | 100.0% | $-487,185,000 | -4207.1% |
| 2022 | $35.4M | +20.4% | $35.4M | 100.0% | $-258,279,000 | -730.0% |
| 2021 | $29.4M | -31.6% | $29.4M | 100.0% | $-188,008,000 | -639.7% |
| 2020 | $43.0M | -14.1% | $43.0M | 100.0% | $-110,697,000 | -257.5% |
| 2019 | $50.0M | +148.2% | $50.0M | 100.0% | $-54,120,000 | -108.2% |
| 2018 | $20.2M | - | $20.2M | 100.0% | $-40,329,000 | -200.0% |
| 2017 | $0 | - | $-26,586,000 | - | $-31,129,000 | - |
Full RVMD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RVMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RVMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RVMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRVMD — Frequently Asked Questions
Quick answers to the most common questions about buying RVMD stock.
Is RVMD's revenue growth accelerating or slowing?
RVMD TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RVMD's long-term revenue growth rate?
Revolution Medicines, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RVMD's revenue distributed by segment?
RVMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.